Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia
暂无分享,去创建一个
T. Fukaya | K. Kawaguchi | Yasuhiro Tanaka | I. Shinzato | K. Matsubara | T. Takafuta | H. Nigami | A. Iwata | Yasuhito Takeuchi
[1] F. Walther,et al. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura , 2013, Vox sanguinis.
[2] A. James,et al. How I treat thrombocytopenia in pregnancy. , 2013, Blood.
[3] T. Tomimatsu,et al. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura , 2012, American journal of hematology.
[4] Y. Tomiyama,et al. Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia. , 2011, Blood.
[5] M. Crowther,et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. , 2011, Blood.
[6] Y. Ishigatsubo,et al. A retrospective analysis of obstetric patients with idiopathic thrombocytopenic purpura: a single center study , 2010, International journal of hematology.
[7] Drew Provan,et al. International consensus report on the investigation and management of primary immune thrombocytopenia. , 2010, Blood.
[8] R. Raffaelli,et al. Idiopathic thrombocytopenic purpura in pregnancy: analysis of 43 consecutive cases followed at a single Italian institution , 2006, Annals of Hematology.
[9] J. Kelton,et al. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. , 2003, Blood.
[10] W. Ouwehand,et al. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy , 2003, British journal of haematology.
[11] Y. Ikeda,et al. Nationwide Study of Idiopathic Thrombocytopenic Purpura in Pregnant Women and the Clinical Influence on Neonates , 2002, International journal of hematology.
[12] J. Kelton. Idiopathic thrombocytopenic purpura complicating pregnancy. , 2002, Blood reviews.
[13] I. Khouri,et al. Immune Thrombocytopenic Purpura , 2018 .
[14] J. Kelton,et al. Management of idiopathic thrombocytopenic purpura in pregnancy. , 2000, Seminars in hematology.
[15] B. Weill,et al. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. , 1998, Blood.
[16] J. Bussel,et al. Comparison of Platelet Counts in First and Second Newborns of Mothers With Immune Thrombocytopenic Purpura , 1997, Obstetrics and gynecology.
[17] T. Kelly,et al. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. , 1997, American journal of obstetrics and gynecology.
[18] A. Homans. Thrombocytopenia in the neonate. , 1996, Pediatric clinics of North America.
[19] R. Sharon,et al. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura , 1994, American journal of hematology.
[20] L. Braitman,et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura , 1990, The New England journal of medicine.